Publicaciones (72) Publicaciones en las que ha participado algún/a investigador/a

2020

  1. A New Workflow for Image-Guided Intraoperative Electron Radiotherapy Using Projection-Based Pose Tracking

    IEEE Access, Vol. 8, pp. 137501-137516

  2. A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study

    Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 420-428

  3. Association of visual and quantitative heterogeneity of 18F-FDG PET images with treatment response in locally advanced rectal cancer: A feasibility study

    PloS one, Vol. 15, Núm. 11, pp. e0242597

  4. Atypical patterns of response and progression in the era of immunotherapy combinations

    Future Oncology, Vol. 16, Núm. 23, pp. 1707-1713

  5. BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

    Nature Medicine, Vol. 26, Núm. 6, pp. 878-885

  6. Binge drinking and risk of breast cancer: Results from the SUN (‘Seguimiento universidad de Navarra’) project

    Nutrients, Vol. 12, Núm. 3

  7. CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity

    Immunity, Vol. 52, Núm. 5, pp. 856-871.e8

  8. Capturing hyperprogressive disease with immune-checkpoint inhibitors using RECIST 1.1 criteria

    Clinical Cancer Research, Vol. 26, Núm. 8, pp. 1846-1855

  9. Cellular cytotoxicity is a form of immunogenic cell death

    Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1

  10. Complete cytoreductive surgery, the key factor for survival in advanced ovarian cancer. Experience of an intermediate volume hospital

    European Journal of Gynaecological Oncology, Vol. 41, Núm. 6, pp. 906-912

  11. Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

    Cancer Cell, Vol. 38, Núm. 4, pp. 500-515.e3

  12. Critical reappraisal of phase III trials with immune checkpoint inhibitors in non-proportional hazards settings

    European Journal of Cancer, Vol. 136, pp. 159-168

  13. Current and novel therapeutic opportunities for systemic therapy in biliary cancer

    British Journal of Cancer, Vol. 123, Núm. 7, pp. 1047-1059

  14. Design and implementation of a teaching project for the formation of medical identity in medical students

    Educacion Medica, Vol. 21, Núm. 3, pp. 207-211

  15. ESMO Clinical Research Observatory (ECRO): improving the efficiency of clinical research through rationalisation of bureaucracy

    ESMO Open, Vol. 5, Núm. 3

  16. ESMO management and treatment adapted recommendations in the COVID-19 era: Gynaecological malignancies

    ESMO Open, Vol. 5

  17. ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in borderline-resected pancreatic cancer

    Clinical and Translational Radiation Oncology, Vol. 23, pp. 91-99

  18. ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in unresected pancreatic cancer

    Radiotherapy and Oncology, Vol. 148, pp. 57-64

  19. ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy with electrons (IOERT) in breast cancer

    Radiotherapy and Oncology, Vol. 149, pp. 150-157

  20. ESTRO/ACROP IORT recommendations for intraoperative radiation therapy in locally recurrent rectal cancer

    Clinical and Translational Radiation Oncology, Vol. 24, pp. 41-48